Filing Details
- Accession Number:
- 0001209191-20-006298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-04 16:15:33
- Reporting Period:
- 2020-01-31
- Accepted Time:
- 2020-02-04 16:15:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197036 | I Bruce Sachs | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-31 | 20,000 | $53.85 | 31,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,700 | $224.02 | 29,510 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,858 | $224.98 | 27,652 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 4,198 | $226.32 | 23,454 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 5,644 | $227.01 | 17,810 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 300 | $227.66 | 17,510 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 600 | $228.33 | 16,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 500 | $229.90 | 16,410 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,200 | $230.87 | 15,210 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,200 | $232.04 | 14,010 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 1,800 | $233.13 | 12,210 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 900 | $234.15 | 11,310 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-31 | 100 | $235.40 | 11,210 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-31 | 20,000 | $0.00 | 20,000 | $53.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $224.02 (range $223.58 to $224.40).
- Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $224.98 (range $224.66 to $225.21).
- Open market sales reported on this line occurred at a weighted average price of $226.32 (range $225.62 to $226.60).
- Open market sales reported on this line occurred at a weighted average price of $227.01 (range $226.70 to $227.59).
- Open market sales reported on this line occurred at a weighted average price of $227.66 (range $227.62 to $227.70).
- Open market sales reported on this line occurred at a weighted average price of $228.33 (range $227.97 to $228.78).
- Open market sales reported on this line occurred at a weighted average price of $229.90 (range $229.16 to $230.12).
- Open market sales reported on this line occurred at a weighted average price of $230.87 (range $230.32 to $231.23).
- Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.45 to $232.42).
- Open market sales reported on this line occurred at a weighted average price of $233.13 (range $232.69 to $233.49).
- Open market sales reported on this line occurred at a weighted average price of $234.15 (range $233.77 to $234.66).
- Fully vested.
Billionaire Hedge Funds
